SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001640455-20-000120
Filing Date
2020-11-02
Accepted
2020-11-02 07:04:54
Documents
16
Period of Report
2020-11-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K jnce-20201102.htm   iXBRL 8-K 41984
2 EX-99.1 jnceexhibit991.htm EX-99.1 35762
8 image_11.jpg GRAPHIC 26625
  Complete submission text file 0001640455-20-000120.txt   269502

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnce-20201102.xsd EX-101.SCH 2424
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT jnce-20201102_cal.xml EX-101.CAL 714
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnce-20201102_def.xml EX-101.DEF 1651
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnce-20201102_lab.xml EX-101.LAB 24975
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnce-20201102_pre.xml EX-101.PRE 13191
9 EXTRACTED XBRL INSTANCE DOCUMENT jnce-20201102_htm.xml XML 11205
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Filer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37998 | Film No.: 201278949
SIC: 2836 Biological Products, (No Diagnostic Substances)